Activation of the GLP-1 receptor by a non-peptidic agonist
文献类型:期刊论文
作者 | Zhao, Peishen1; Liang, Yi-Lynn1; Belousoff, Matthew J.1; Deganutti, Giuseppe2; Fletcher, Madeleine M.1; Willard, Francis S.3; Bell, Michael G.3; Christe, Michael E.3; Sloop, Kyle W.3; Inoue, Asuka4 |
刊名 | NATURE |
出版日期 | 2020-01-08 |
页码 | 432-+ |
ISSN号 | 0028-0836 |
DOI | 10.1038/s41586-019-1902-z |
通讯作者 | Danev, Radostin(rado@m.u-tokyo.ac.jp) ; Sexton, Patrick M.(patrick.sexton@monash.edu) ; Wootten, Denise(denise.wootten@monash.edu) |
英文摘要 | Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity(1). Structures of active receptors reveal peptide agonists engage deep within the receptor core, leading to an outward movement of extracellular loop 3 and the tops of transmembrane helices 6 and 7, an inward movement of transmembrane helix 1, reorganization of extracellular loop 2 and outward movement of the intracellular side of transmembrane helix 6, resulting in G-protein interaction and activation(2-6). Here we solved the structure of a non-peptide agonist, TT-OAD2, bound to the glucagon-like peptide-1 (GLP-1) receptor. Our structure identified an unpredicted non-peptide agonist-binding pocket in which reorganization of extracellular loop 3 and transmembrane helices 6 and 7 manifests independently of direct ligand interaction within the deep transmembrane domain pocket. TT-OAD2 exhibits biased agonism, and kinetics of G-protein activation and signalling that are distinct from peptide agonists. Within the structure, TT-OAD2 protrudes beyond the receptor core to interact with the lipid or detergent, providing an explanation for the distinct activation kinetics that may contribute to the clinical efficacy of this compound series. This work alters our understanding of the events that drive the activation of class B receptors. |
WOS关键词 | CRYO-EM STRUCTURE ; GENERAL FORCE-FIELD ; G-PROTEIN ; PEPTIDE-1 RECEPTOR ; MOLECULAR-DYNAMICS ; CRYSTAL-STRUCTURE ; COMPLEX ; AUTOMATION ; MODULATION ; EFFICACY |
WOS研究方向 | Science & Technology - Other Topics |
语种 | 英语 |
出版者 | NATURE PUBLISHING GROUP |
WOS记录号 | WOS:000510801600002 |
源URL | [http://119.78.100.183/handle/2S10ELR8/281605] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Danev, Radostin; Sexton, Patrick M.; Wootten, Denise |
作者单位 | 1.Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia 2.Univ Essex, Sch Biol Sci, Colchester, Essex, England 3.Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA 4.Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan 5.Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai, Peoples R China 6.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China 7.Fudan Univ, Sch Pharm, Shanghai, Peoples R China 8.Mayo Clin, Scottsdale, AZ USA 9.Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan |
推荐引用方式 GB/T 7714 | Zhao, Peishen,Liang, Yi-Lynn,Belousoff, Matthew J.,et al. Activation of the GLP-1 receptor by a non-peptidic agonist[J]. NATURE,2020:432-+. |
APA | Zhao, Peishen.,Liang, Yi-Lynn.,Belousoff, Matthew J..,Deganutti, Giuseppe.,Fletcher, Madeleine M..,...&Wootten, Denise.(2020).Activation of the GLP-1 receptor by a non-peptidic agonist.NATURE,432-+. |
MLA | Zhao, Peishen,et al."Activation of the GLP-1 receptor by a non-peptidic agonist".NATURE (2020):432-+. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。